Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Innophos to buy Novel Ingredients

by Melody M. Bomgardner
August 7, 2017 | A version of this story appeared in Volume 95, Issue 32

The specialties firm Innophos will acquire Novel Ingredients, a New Jersey-based maker of dietary supplement ingredients, for $125 million in cash. The move is part of Innophos’s strategy to grow its food, health, and nutrition portfolio. The company named megatrends such as health and wellness, energized aging, and clean labels as drivers for the deal. Novel Ingredients had revenues of $100 million, growing at 19% per year. The company, with 100 employees, supplies botanicals, proteins, amino acids, and customized formulations.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.